Reduction of the erythema response to ultraviolet light by nonsteroidal anti-inflammatory agents

Edwards E, Horwitz S, Frost P

Arch Dermatol Res. 1982:272;263-267.

A study was performed to determine the effect of nonsteroidal anti-inflammatory agents (NSAIA) on erythemal response after exposure to ultraviolet B (UV-B) radiation. Results of this study proved the minimal dose of light required to produce erythema was increased by 240% when NSAIA were administered two hours before phototherapy exposure. This means that giving patients NSAIA before phototherapy sessions can improve patient erythema and tolerance for higher doses of UV-B.

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

March 11, 2022

Full Article Yiu Z, Ashcroft D, Evans I, McElhone K, Lunt M, Smith C, Walton S, Murphy R, Reynolds N, Ormerod A, Griffiths C, Warren

Moderate exercise and bright light treatment in overweight and obese individuals

March 11, 2022

Full Article Dunai A, Novak M, Chung S, Kayumov L, Keszei A, Levitan R, Shapiro C Obesity. 2007;15(7):1749-1757. “This randomized, controlled study is the first

Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study

March 11, 2022

Full Article Malanos D Stern R J Am Acad Dermatol. 2007;57(2):231-7. doi:10.1016/j.jaad.2007.04.027 A common fear associated with the use of psoralen plus ultraviolet A (PUVA)

Reduction of the erythema response to ultraviolet light by nonsteroidal anti-inflammatory agents

Edwards E, Horwitz S, Frost P

Other Articles

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Moderate exercise and bright light treatment in overweight and obese individuals

Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study

CALL 1-800-DAAVLIN OR FILL OUT THE FORM BELOW

CALL 1-800-DAAVLIN OR
FILL OUT THE FORM BELOW